Revolution Medicines (RVMD) Liabilities and Shareholders Equity (2019 - 2026)
Revolution Medicines (RVMD) posted Liabilities and Shareholders Equity of $4.32 billion for Q2 2026, up 77.9% from $2.43 billion a year earlier and up 91.8% from the prior quarter.
Powered by 
Analysis
Revolution Medicines (RVMD) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Revolution Medicines' Liabilities and Shareholders Equity came in at $2.35 billion, down 8.0% from FY2024.
- Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 32.9% (FY2020 to FY2025).
- In prior years, Revolution Medicines' Liabilities and Shareholders Equity was $2.56 billion in FY2024 (+24.1%), $2.06 billion in FY2023 (+153.9%), $811.93 million in FY2022 (+10.0%) and $737.99 million in FY2021 (+30.1%).
- The Q2 2026 figure stands as the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2019.
- On a year-over-year basis, Liabilities and Shareholders Equity increased in six of the last eight quarters, with growth averaging 31.8%.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was Q4 2023, with growth of 153.9%; the weakest was Q2 2022, with a decline of 18.2%.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $2.25 billion (Q1 2026), $2.35 billion (Q4 2025) and $2.25 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Revolution Medicines | 37.70 Bn | 27.90 Bn | - | 4.32 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.32 Bn |
| Mar 31, 2026 | 2.25 Bn |
| Dec 31, 2025 | 2.35 Bn |
| Sep 30, 2025 | 2.25 Bn |
| Jun 30, 2025 | 2.43 Bn |
| Mar 31, 2025 | 2.37 Bn |
| Dec 31, 2024 | 2.56 Bn |
| Sep 30, 2024 | 1.76 Bn |
| Jun 30, 2024 | 1.81 Bn |
| Mar 31, 2024 | 1.91 Bn |
| Dec 31, 2023 | 2.06 Bn |
| Sep 30, 2023 | 984.23 Mn |
| Jun 30, 2023 | 1.07 Bn |
| Mar 31, 2023 | 1.07 Bn |
| Dec 31, 2022 | 811.93 Mn |
| Sep 30, 2022 | 825.91 Mn |
| Jun 30, 2022 | 632.80 Mn |
| Mar 31, 2022 | 682.77 Mn |
| Dec 31, 2021 | 737.99 Mn |
| Sep 30, 2021 | 734.98 Mn |
API Access
Revolution Medicines Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RVMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "RVMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=RVMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();